Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor α: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Rheumatology (Oxford). 2016 Jul;55(7):1336-7. doi: 10.1093/rheumatology/kew200. Epub 2016 Apr 26.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antirheumatic Agents / adverse effects
  • Arthritis, Rheumatoid / drug therapy*
  • Biological Products / adverse effects*
  • Female
  • Humans
  • Immunocompromised Host
  • Male
  • Middle Aged
  • Opportunistic Infections / immunology*
  • Pneumonia, Pneumocystis / immunology*
  • Registries
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Biological Products
  • TNF protein, human
  • Tumor Necrosis Factor-alpha